Lv11
86 积分 2023-05-10 加入
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
3小时前
已完结
Engineered sgRNA captures single-stranded donor template and delivers at the DSB site to enhance HDR
13天前
已完结
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial
22天前
已完结
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
28天前
已完结
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells
29天前
已完结
T‐cell receptor &agr;&bgr;+ and CD19+ cell–depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency
1个月前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
1个月前
已完结
Improved vectors and genome-wide libraries for CRISPR screening
1个月前
已完结
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
2个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
3个月前
已完结
皖公网安备34019202002308
